759 related articles for article (PubMed ID: 16470535)
1. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
Won DI; Jeong HD; Kim YL; Suh JS
Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
Saw CL; Bray RA; Gebel HM
Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
[TBL] [Abstract][Full Text] [Related]
4. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
Delgado JC; Eckels DD
Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
[TBL] [Abstract][Full Text] [Related]
5. Crossmatching technique facilitating kidney transplantation.
Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
[TBL] [Abstract][Full Text] [Related]
6. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
[TBL] [Abstract][Full Text] [Related]
7. T-cell flow-cytometry crossmatch and long-term renal graft survival.
Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
[TBL] [Abstract][Full Text] [Related]
10. Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation.
McAlister CC; Gao ZH; McAlister VC; Gupta R; Wright JR; MacDonald AS; Peltekian K
Liver Transpl; 2004 Feb; 10(2):315-9. PubMed ID: 14762873
[TBL] [Abstract][Full Text] [Related]
11. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.
Lobo PI; Isaacs RB; Spencer CE; Pruett TL; Sanfey HA; Sawyer RG; McCullough C
Transpl Int; 2002 Nov; 15(11):563-9. PubMed ID: 12461661
[TBL] [Abstract][Full Text] [Related]
12. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
Bray RA; Lebeck LK; Gebel HM
Transplantation; 1989 Nov; 48(5):834-40. PubMed ID: 2815255
[TBL] [Abstract][Full Text] [Related]
13. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
[TBL] [Abstract][Full Text] [Related]
14. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
[TBL] [Abstract][Full Text] [Related]
16. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
[TBL] [Abstract][Full Text] [Related]
17. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
[TBL] [Abstract][Full Text] [Related]
18. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
AlMahri A; Holgersson J; Alheim M
Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
Arnold ML; Dechant M; Doxiadis II; Spriewald BM
Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
[TBL] [Abstract][Full Text] [Related]
20. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
